Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis
- 28 September 2004
- journal article
- clinical trial
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 296 (5) , 235-239
Abstract
UVA1-mediated effects regarding vascular dysregulation as a primary pathogenetic factor of systemic sclerosis skin lesions have so far not been investigated. Pre- and posttherapy skin biopsies of four patients were evaluated immunohistochemically for angiostatic, angiogenic and angioapoptotic features. Immunohistochemistry revealed a partial pretherapy loss of endothelial CD31 and CD34 expression accompanied by a posttherapy increase of CD34+ cells. Simultaneously, VEGF and M30 CytoDEATH immunolabeling demonstrated UVA1-induced neovascularization and decreased endothelial apoptosis. Our results suggest that UVA1 irradiation exerts its positive effects by a modulation of endothelial regulation/transformation beside the proposed induction of T cell apoptosis and collagenases.Keywords
This publication has 5 references indexed in Scilit:
- Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosisJournal of the American Academy of Dermatology, 2004
- Phototherapy for scleroderma: biologic rationale, results, and promiseCurrent Opinion in Rheumatology, 2002
- Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cellsJournal of the American Academy of Dermatology, 2001
- Endothelial Injury in Internal Organs of University of California at Davis Line 200 (UCD 200) Chickens, an Animal Model for Systemic Sclerosis (Scleroderma)Journal of Autoimmunity, 2000
- Adhesion of Leukocytes to Dermal Endothelial Cells Is Induced After Single-Dose, But Reduced After Repeated Doses of UVAJournal of Investigative Dermatology, 1997